chr1-171652385-C-T

Variant summary

Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BA1BS3_Supporting

This summary comes from the ClinGen Evidence Repository: The c.227G>A variant in MYOC is a missense variant predicted to cause substitution of Arginine by Lysine at amino acid 76 (p.Arg76Lys). The highest minor allele frequency of this variant was in the South Asian population of gnomAD (v2.1.1) = 0.3468, which met the ≥ 0.01 threshold set for BA1 (10,613 alleles out of 30,602, meeting the threshold of ≥ 5 of at least 2,000 observed alleles). The REVEL score = 0.203, which was neither above nor below the thresholds for PP3 (≥ 0.7) or BP4 (≤ 0.15), predicting a damaging or benign impact on MYOC function. Previous studies (PMIDs: 16466712 and 35196929) demonstrated that the Arg76Lys protein had similar solubility and secretion levels to wild type myocilin protein and met the OddsPath threshold for BS3_Moderate (< 0.23), indicating that this variant did not impact protein function. As BA1 was met, PP1 did not apply and segregations were not counted. Although probands with juvenile or primary open angle glaucoma have been reported carrying this variant, PM2_Supporting was not met, therefore PS4 did not apply. In summary, this variant was classified as benign (BA1 is a stand-alone criterion for a benign level of pathogenicity) for juvenile open angle glaucoma based on the ACMG/AMP criteria met, as specified by the ClinGen Glaucoma VCEP (v1, 12 Oct 2021): BA1, BS3_Moderate. LINK:https://erepo.genome.network/evrepo/ui/classification/CA200294/MONDO:0020367/019

Frequency

Genomes: 𝑓 0.11 ( 1253 hom., cov: 32)
Exomes 𝑓: 0.14 ( 17310 hom. )

Consequence

MYOC
NM_000261.2 missense

Scores

2
16

Clinical Significance

Benign reviewed by expert panel U:1B:8

Conservation

PhyloP100: 2.86
Variant links:
Genes affected
MYOC (HGNC:7610): (myocilin) MYOC encodes the protein myocilin, which is believed to have a role in cytoskeletal function. MYOC is expressed in many occular tissues, including the trabecular meshwork, and was revealed to be the trabecular meshwork glucocorticoid-inducible response protein (TIGR). The trabecular meshwork is a specialized eye tissue essential in regulating intraocular pressure, and mutations in MYOC have been identified as the cause of hereditary juvenile-onset open-angle glaucoma. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -9 ACMG points.

BS3
For more information check the summary or visit ClinGen Evidence Repository.
BA1
For more information check the summary or visit ClinGen Evidence Repository.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MYOCNM_000261.2 linkc.227G>A p.Arg76Lys missense_variant Exon 1 of 3 ENST00000037502.11 NP_000252.1 Q99972A0A0S2Z421

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MYOCENST00000037502.11 linkc.227G>A p.Arg76Lys missense_variant Exon 1 of 3 1 NM_000261.2 ENSP00000037502.5 Q99972
MYOCENST00000638471.1 linkn.130+97G>A intron_variant Intron 1 of 3 5 ENSP00000491206.1 A0A1W2PP09

Frequencies

GnomAD3 genomes
AF:
0.108
AC:
16415
AN:
152108
Hom.:
1252
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0259
Gnomad AMI
AF:
0.130
Gnomad AMR
AF:
0.102
Gnomad ASJ
AF:
0.138
Gnomad EAS
AF:
0.0758
Gnomad SAS
AF:
0.345
Gnomad FIN
AF:
0.169
Gnomad MID
AF:
0.133
Gnomad NFE
AF:
0.133
Gnomad OTH
AF:
0.112
GnomAD3 exomes
AF:
0.147
AC:
37010
AN:
251002
Hom.:
3720
AF XY:
0.160
AC XY:
21758
AN XY:
135594
show subpopulations
Gnomad AFR exome
AF:
0.0218
Gnomad AMR exome
AF:
0.0997
Gnomad ASJ exome
AF:
0.127
Gnomad EAS exome
AF:
0.0817
Gnomad SAS exome
AF:
0.347
Gnomad FIN exome
AF:
0.164
Gnomad NFE exome
AF:
0.136
Gnomad OTH exome
AF:
0.143
GnomAD4 exome
AF:
0.141
AC:
206715
AN:
1461048
Hom.:
17310
Cov.:
33
AF XY:
0.148
AC XY:
107803
AN XY:
726668
show subpopulations
Gnomad4 AFR exome
AF:
0.0237
Gnomad4 AMR exome
AF:
0.102
Gnomad4 ASJ exome
AF:
0.132
Gnomad4 EAS exome
AF:
0.0568
Gnomad4 SAS exome
AF:
0.341
Gnomad4 FIN exome
AF:
0.162
Gnomad4 NFE exome
AF:
0.134
Gnomad4 OTH exome
AF:
0.137
GnomAD4 genome
AF:
0.108
AC:
16424
AN:
152226
Hom.:
1253
Cov.:
32
AF XY:
0.112
AC XY:
8337
AN XY:
74430
show subpopulations
Gnomad4 AFR
AF:
0.0258
Gnomad4 AMR
AF:
0.102
Gnomad4 ASJ
AF:
0.138
Gnomad4 EAS
AF:
0.0762
Gnomad4 SAS
AF:
0.346
Gnomad4 FIN
AF:
0.169
Gnomad4 NFE
AF:
0.133
Gnomad4 OTH
AF:
0.112
Alfa
AF:
0.120
Hom.:
760
Bravo
AF:
0.0936
TwinsUK
AF:
0.131
AC:
484
ALSPAC
AF:
0.125
AC:
482
ESP6500AA
AF:
0.0277
AC:
122
ESP6500EA
AF:
0.134
AC:
1155
ExAC
AF:
0.150
AC:
18209
Asia WGS
AF:
0.199
AC:
693
AN:
3478
EpiCase
AF:
0.137
EpiControl
AF:
0.139

ClinVar

Significance: Benign
Submissions summary: Uncertain:1Benign:8
Revision: reviewed by expert panel
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:3
Jan 28, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Oct 01, 2016
CeGaT Center for Human Genetics Tuebingen
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Mar 03, 2015
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is associated with the following publications: (PMID: 18449353, 17361544, 28792703, 22449891, 15025728, 27884173, 21168818, 23029558, 14688426, 23517641, 16466712) -

-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

not specified Benign:2
Jun 10, 2014
Eurofins Ntd Llc (ga)
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Glaucoma 1, open angle, A Benign:1
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -

Glaucoma Benign:1
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -

Glaucoma of childhood Benign:1
Mar 05, 2022
ClinGen Glaucoma Variant Curation Expert Panel
Significance: Benign
Review Status: reviewed by expert panel
Collection Method: curation

The c.227G>A variant in MYOC is a missense variant predicted to cause substitution of Arginine by Lysine at amino acid 76 (p.Arg76Lys). The highest minor allele frequency of this variant was in the South Asian population of gnomAD (v2.1.1) = 0.3468, which met the >= 0.01 threshold set for BA1 (10,613 alleles out of 30,602, meeting the threshold of >= 5 of at least 2,000 observed alleles). The REVEL score = 0.203, which was neither above nor below the thresholds for PP3 (>= 0.7) or BP4 (<= 0.15), predicting a damaging or benign impact on MYOC function. Previous studies (PMIDs: 16466712 and 35196929) demonstrated that the Arg76Lys protein had similar solubility and secretion levels to wild type myocilin protein and met the OddsPath threshold for BS3_Moderate (< 0.23), indicating that this variant did not impact protein function. As BA1 was met, PP1 did not apply and segregations were not counted. Although probands with juvenile or primary open angle glaucoma have been reported carrying this variant, PM2_Supporting was not met, therefore PS4 did not apply. In summary, this variant was classified as benign (BA1 is a stand-alone criterion for a benign level of pathogenicity) for juvenile open angle glaucoma based on the ACMG/AMP criteria met, as specified by the ClinGen Glaucoma VCEP (v1, 12 Oct 2021): BA1, BS3_Moderate. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.086
BayesDel_addAF
Benign
-0.63
T
BayesDel_noAF
Benign
-0.53
CADD
Benign
17
DANN
Benign
0.89
DEOGEN2
Benign
0.38
T
Eigen
Benign
-0.26
Eigen_PC
Benign
-0.26
FATHMM_MKL
Uncertain
0.86
D
LIST_S2
Benign
0.54
T
MetaRNN
Benign
0.0041
T
MetaSVM
Benign
-0.61
T
MutationAssessor
Uncertain
2.8
M
PrimateAI
Benign
0.37
T
PROVEAN
Benign
-0.87
N
REVEL
Benign
0.20
Sift
Benign
0.049
D
Sift4G
Benign
0.077
T
Polyphen
0.018
B
Vest4
0.064
MPC
0.19
ClinPred
0.064
T
GERP RS
3.4
Varity_R
0.13
gMVP
0.47

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs2234926; hg19: chr1-171621525; COSMIC: COSV50674515; API